MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
COAG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Hemab Therapeutics Holdings (COAG) Ownership - Who owns Hemab Therapeutics Holdings?

Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
101 Main Street
Phone
+1 617 553-3952
Employees
72
Web
https://www.hemab.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.62B
P/E Ratio
3.57
Total Cash
457.46M
Projected Growth
N/A
Total Debt
1.03M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
9.79
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
COAG
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for COAG
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
101 Main Street
Phone
+1 617 553-3952
Employees
72
Web
https://www.hemab.com
Who owns Hemab Therapeutics Holdings? COAG symbol Ownership - Tickeron.com